Exploring the therapeutic effects of Moringa Oleifera on inflammation and chronic diseases
DOI:
https://doi.org/10.34117/bjdv10n9-002Keywords:
inflammation, medicinal plants, chronic diseasesAbstract
Background: The inflammatory process is an immune system response to injuries, infections, or harmful stimuli. Chronic Diseases are diseases that are mostly immune-mediated by inflammatory mediators, and according to the World Health Organization, these diseases represent 74% of the causes of death in the world. Moringa oleifera (M. oleifera), is a versatile plant rich in bioactive compounds, has garnered attention for its potential therapeutic properties. Objective: this study aims to investigate the anti-inflammatory properties of M. oleifera and its potential influence on chronic diseases as well. Methods: This review was performed based systematic analysis of literature. Results: Anti-inflammatory activity was observed through the reduction in levels of IL-1, IL-6, IL-10, TNF-alpha, prostaglandin E2, and COX-2. Additionally, anti-hyperglycemic effects, normalization of lipid profiles, regeneration of hepatocytes and pancreatic beta cells, and a reduction in the concentration of reactive oxygen species were also described. Conclusion: These findings support the use of the M. oleifera plant as an effective treatment for diseases/disorders associated with inflammation.
References
Alhakmani, F.; Kumar, S. Estimation of total phenolic content, in-vitro antioxidant and anti-inflammatory activity of flowers of Moringa oleifera. Asian Pacific Journal of Tropical Biomedicine, v. 3, n. 8, p. 623-627, 2013.
Alhakmani, F.; Kumar, S.; Khan, S. A. Estimation of total phenolic content, in-vitro antioxidant and anti-inflammatory activity of flowers of Moringa oleifera. Asian Pac. J. Trop. Biomed., v. 3, n. 8, p. 623-627, 2013.
Amir, M.; Javed, S. A.; Kumar, H. Design and synthesis of 3-[3-(substituted phenyl)-4-piperidin-1-ylmethyl/-4-morpholin-4-ylmethyl-4,5-dihydro-isoxazol-5-yl]-1H-indoles as potent anti-inflammatory agents. Medicinal Chemistry Research, v. 19, n. 3, p. 299-310, 2010.
Amir, M.; Javed, S. A.; Kumar, H. Design and synthesis of 3-[3-(substituted phenyl)-4-piperidin-1-ylmethyl/-4-morpholin-4-ylmethyl-4,5-dihydro-isoxazol-5-yl]-1H-indoles as potent anti-inflammatory agents. Medicinal Chemistry Research, v. 19, n. 3, p. 299-310, 2010.
Anwar, F.; Latif, S.; Ashraf, M.; Gilani, A. H. Moringa oleifera: A food plant with multiple medicinal uses. Phytotherapy Research, v. 21, p. 17-25, 2007.
Aprioku, J. S.; Robinson, O.; Obianime, A. W.; Tamuno, I. Moringa supplementation improves immunological indices and hematological abnormalities in seropositive patients receiving HAARTs. African Health Sciences, v. 22, n. 2, p. 1-11, 2022.
Ayala, A.; Muñoz, M. F.; Argüelles, S. Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxidative Medicine and Cellular Longevity, 2014, 31, 2014.
Bennett, R. N.; Mellon, F. A.; Foidl, N.; Pratt, J. H.; Dupont, M. S.; Perkins, L. Profiling glucosinolates and phenolics in vegetative and reproductive tissues of the multi-purpose trees Moringa oleifera L. (horseradish tree) and Moringa stenopetala L. Journal of Agricultural and Food Chemistry, 2003.
Berkovich, L.; Earon, G.; Ron, I.; Rimmon, A.; Vexler, A.; Lev-Ari, S. Moringa Oleifera aqueous leaf extract down-regulates nuclear factor-kappaB and increases cytotoxic effect of chemotherapy in pancreatic cancer cells. BMC Complement Altern Med, v. 13, p. 212, 2013. doi: 10.1186/1472-6882-13-212
Bosch, C. H. Moringa oleifera Lam. Record from PROTA4U. PROTA (Plant Resources of Tropical Africa/Ressources végétales de l’Afrique tropicale), 2004.
BRASIL. Ministério da Saúde. Diretrizes e recomendações para o cuidado integral de doenças crônicas não-transmissíveis: Promoção da saúde, vigilância, prevenção e assistência. Brasília: Ministério da Saúde, 2008.
BRASIL. Ministério da Saúde. Saúde apresenta atual cenário das doenças não transmissíveis no Brasil. Disponível em: <https://www.gov.br/saude/pt-br/assuntos/noticias/2021/setembro/saude-apresenta-atual-cenario-das-doencas-nao-transmissiveis-no-brasil>. Acesso em: 30 jul. 2024.
Chua, L. S. A review on plant-based Rutin extraction methods and its pharmacological activities. Journal of Ethnopharmacology, v. 150, n. 3, p. 805-817, 2013.
Colotta, F.; Allavena, P.; Sica, A.; et al. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis, v. 30, n. 7, p. 1073-1081, 2009.
Fard, M. T.; Arulselvan, P.; Karthivashan, G.; Adam, S. K.; Fakurazi, S. Bioactive extract from Moringa oleifera inhibits the pro-inflammatory mediators in lipopolysaccharide-stimulated macrophages. Pharmacognosy Magazine, v. 11, Supl. 4, p. S556–S563, 2015.
Filho, V. C.; Zanchett, C. C. C. Advanced Phytotherapy: A Chemical, Biological, and Nutritional Approach, 2020.
Fuchs, D.; Hausen, A.; Reibnegger, G.; Werner, E. R.; Werner-Felmayer, G.; Dierich, M. P.; Wachter, H. Immune activation and the anaemia associated with chronic inflammatory disorders. European Journal of Haematology, v. 46, p. 65-70, 1991.
Fuchs, F. D.; Wannmacher, L. Farmacologia Clínica: Fundamentos da Terapêutica Racional. 4. ed. Rio de Janeiro: Guanabara Koogan S. A, 2010.
Fuchs, O. Transcription factor NF-κB inhibitors as single therapeutic agents or in combination with classical chemotherapeutic agents for the treatment of hematologic malignancies. Current Molecular Pharmacology, v. 3, n. 3, p. 98-122, 2010.
Ganeshpurkar, A.; Saluja, A. K. The pharmacological potential of rutin. Saudi Pharmaceutical Journal, v. 25, n. 2, p. 149-164, 2017.
Gimenis, J. M. Avaliação da atividade antioxidante, fotoprotetora e antiglicante dos extratos das folhas e flores de Moringa oleifera. 2015. Dissertação (Mestrado) - Unesp, Assis, Brasil, 2015.
Gupta, S. C.; Sundaram, C.; Reuter, S.; Aggarwal, B. B. Inhibiting NF-κB activation by small molecules as a therapeutic strategy. Biochimica et Biophysica Acta, v. 1799, n. 10-12, p. 775-787, 2010.
Gustafson, B.; Gogg, S.; Hedjazifar, S.; Jenndahl, L.; Hammarstedt, A.; Smith, U. Inflammation and impaired adipogenesis in hypertrophic obesity in man. American Journal of Physiology-Endocrinology and Metabolism, v. 297, p. E999-E1003, 2009.
Gustafson, B.; Gogg, S.; Hedjazifar, S.; Jenndahl, L.; Hammarstedt, A.; Smith, U. Inflammation and impaired adipogenesis in hypertrophic obesity in man. American Journal of Physiology-Endocrinology and Metabolism, v. 297, p. E999, 2009.
Hackam, G. D.; Anand, S. S. Emerging risk factors for atherosclerotic vascular disease: A critical review of the evidence. JAMA, v. 290, p. 932-940, 2003.
Hanahan, D.; Weinberg, R. A. Hallmarks of cancer: the next generation. Cell, v. 144, n. 5, p. 646-674, 2011.
Hansel, D. E.; Dintzis, R. Z. Fundamentos de Rubin - Patologia [E-book]. Rio de Janeiro: Guanabara Koogan, 2007.
Hulthe, J.; Fagerberg, B. Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study). Arteriosclerosis, Thrombosis, and Vascular Biology, v. 22, p. 1162-1167, 2002.
Hussain, T.; Tan, B.; Yin, Y.; Blachier, F.; Tossou, M. C.; Rahu, N. Oxidative stress and inflammation: What polyphenols can do for us? Oxidative Medicine and Cellular Longevity, 2016, 2016.
Kawabata, K.; Mukai, R.; Ishisaka, A. Quercetin and related polyphenols: New insights and implications for their bioactivity and bioavailability. Food Function, v. 6, n. 5, p. 1399-1417, 2015.
Khovidhunkit, W.; Kim, M. S.; Memon, R. A.; Shigenaga, J. K.; Moser, A. H.; Feingold, K. R.; et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: Mechanisms and consequences to the host. Journal of Lipid Research, v. 45, p. 1169-1196, 2004.
Kim, J. K.; Park, S. U. Quercetin and its role in biological functions: An updated review. EXCLI Journal, v. 17, p. 856-863, 2018.
Klasco, R. K. (Ed.). DrugPoint®. Thomson MICROMEDEX, Greenwood Village, Colorado, USA. Disponível em: <http://www.thomsonhc.com/>. Acesso em: 15 out. 2023.
Kumar, R.; Clermont, G.; Vodovotz, Y.; Chow, C. C. The dynamics of acute inflammation. Journal of Theoretical Biology, v. 230, p. 145-155, 2004.
Lee, H. J.; Jeong, Y. J.; Lee, T. S.; Park, Y. Y.; Chae, W. G.; Chung, I. K. Moringa fruit inhibits LPS-induced NO/iNOS expression through suppressing the NF-kappa B activation in RAW264.7 cells. Am. J. Chin. Med., v. 41, n. 5, p. 1109-1123, 2013.
Loa, M.; Hidayanty, H.; Arifuddin, S.; Ahmad, M.; Hadju, V. Moringa oleifera leaf flour biscuits increase the index of erythrocytes in pregnant women with anemia. Department of Midwifery, Graduate School, Hasanuddin University, Indonesia. Department of Nutrition, Faculty of Public Health, Hasanuddin University, Indonesia, 2021.
Malta, D. C.; Cezário, A. C.; Moura, L.; Morais Neto, O. L.; Silva Júnior, J. B. Construção da vigilância e prevenção das doenças crônicas não transmissíveis no contexto do sistema único de saúde. Epidemiologia e Serviços de Saúde, v. 15, p. 47-64, 2006.
Mbikay, M. Therapeutic potential of Moringa oleifera leaves in chronic hyperglycemia and dyslipidemia: a review. Frontiers in Pharmacology, v. 3, p. 24, 2012.
Mena, N. P.; Esparza, A. L.; Núñez, M. T. Regulation of transepithelial transport of iron by hepcidin. Brazilian Journal of Medical and Biological Research, v. 39, p. 191-193, 2006.
Moura, E.; Noordermeer, M. A.; Verhoeven, N.; Verheul, A. F.; Marx, J. J. Iron release from human monocytes after erythrophagocytosis in vitro: An investigation in normal subjects and hereditary hemochromatosis patients. Blood, v. 92, p. 2511-2519, 1998.
Nemeth, E.; Ganz, T. Regulation of iron metabolism by hepcidin. Annual Review of Nutrition, v. 26, p. 323-342, 2006.
Norris, T. L. Porth - Fisiopatologia. 10. ed. Rio de Janeiro: Guanabara Koogan, 2021.
Okumu, M.; Mbaria, J.; Kanja, L.; Gakuya, D.; Kiama, S.; Ochola, F.; Okumu, P. Acute toxicity of the aqueous-methanolic Moringa oleifera (Lam) leaf extract on female Wistar albino rats. International Journal of Basic & Clinical Pharmacology, v. 5, p. 1856-1861, 2016.
Page, M. J.; McKenzie, J. E.; Bossuyt, P. M.; Boutron, I.; Hoffmann, T. C.; Mulrow, C. D.; Shamseer, L.; Tetzlaff, J. M.; Akl, E. A.; Brennan, S. E. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. International Journal of Surgery, v. 88, p. 105906, 2021.
Patlevič, P.; Vašková, J.; Švorc, P.; Vaško, L.; Švorc, P. D. Reactive oxygen species and antioxidant defense in human gastrointestinal diseases. Integrative Medicine Research, v. 5, n. 4, p. 250-258, 2016.
Rahmati, M.; Mobasheri, A.; Mozafari, M. Inflammatory mediators in osteoarthritis: A critical review of the state-of-the-art, current prospects, and future challenges. Bone, v. 85, p. 81-90, 2016.
Reisner, H. M. Patologia: uma abordagem por estudos de casos. Rio de Janeiro: Guanabara Koogan, 2015.
Ribeiro, C.; Oliveira, C. A. M.; Mello, M. A. R. Exercício e prevenção do Diabetes mellitus: importância do modelo experimental utilizando ratos. Motriz, v. 13, n. 1, p. 72-77, 2007.
Ridker, P. M. Novel risk factors and markers for coronary disease. Advances in Internal Medicine, v. 45, p. 391-418, 2000.
Rubin, E.; Strayer, D. S. Rubin’s Pathology: Clinicopathologic Foundations of Medicine. 7. ed. Philadelphia, PA: Walters Kluwer Health, 2015.
Rudge, M. V.; Damasceno, D. C.; Volpato, G. I.; Almeida, F. C.; Calderon, I. M.; Lemonica, I. P. Effect of Ginkgo biloba on the reproductive outcome and oxidative stress biomarkers of streptozotocin-induced diabetic rats. Braz J Med Biol Res, v. 40, p. 1095-1099, 2007.
Sairam, T. V. Home Remedies, vol. II: A Handbook of Herbal Cures for Commons Ailments. New Delhi, India: Penguin, 1999.
Saleem, R. Studies in the Chemical Constituents of Moringa oleifera Lam and Preparation of the Potential Biologically Significant Derivatives of 8-Hydroxyquinoline. 1995. (Dissertation).
Sansbury, B. E.; Spite, M. Resolution of acute inflammation and the role of resolvins in immunity, thrombosis, and vascular biology. Circulation Research, v. 119, n. 1, p. 113-130, 2016.
Shaban, A.; Mishra, G. M.; Nautiyal, R.; et al. In vitro cytotoxicity of Moringa oleifera against different human cancer cell lines. Asian J Pharm Clin Res, v. 5, n. 4, p. 271-272, 2012.
Sharma, S.; Ali, A.; Ali, J.; Sahni, J. K.; Baboota, S. Rutin: Therapeutic potential and recent advances in drug delivery. Expert Opinion on Investigational Drugs. (Publication year not provided).
Shewade, Y.; Tirth, S.; Bhonde, R. Pancreatic islet-cell viability, functionality and oxidative status remain unaffected at pharmacological concentrations of commonly used antibiotics in vitro. J Biosci, v. 26, p. 349-355, 2001.
Stein, O.; Thiery, J.; Stein, Y. Is there a genetic basis for resistance to atherosclerosis? Atherosclerosis, v. 160, p. 1-10, 2002.
Szlachetka, K.; Kut, P. A. S. Cytotoxic and anticancer activity of Moringa oleifera. European Journal of Clinical and Experimental Medicine, v. 18, p. 214-220, 2020.
Ufelle, S. A.; Onyekwelu, K. C.; Achukwu, P. U.; Ezeh, C. O. Haematological effects of leaf extract of Moringa oleifera Lam in normal and myelo-suppressed Wistar rats. African Journal of Biomedical Research, v. 21, p. 87-90, 2018.
Uglie, L. J. The Miracle Tree: Moringa oleifera—Natural Nutrition for the Tropics. Dakar, Senegal: Church World Service, 2001.
Varalakshmi, K.; Nair, S. Anticancer, cytotoxic potential of Moringa oleifera extracts on HeLa cell Line. J Nat Pharm, v. 2, n. 3, p. 138, 2011. doi: 10.4103/2229-5119.86260.
Weiss, G. Iron and anemia of chronic disease. Kidney International, v. 69, p. 12-17, 1999.
Whalen, K.; Finkell, R.; Panavelil, T. A. Farmacologia Ilustrada. Rio de Janeiro: [editora não especificada], 2016.
World Health Organization (Global). Global status report: on noncommunicable diseases. In: World Health Organization (Global) (Ed.). WHO Library, 2014.
World Health Organization. Preventing chronic diseases: A vital investment. Geneva: [editora não especificada], 2005.
Yassa, H. D.; Tohamy, A. F. Extract of Moringa oleifera leaves ameliorates streptozotocin-induced diabetes mellitus in adult rats. Acta Histochem, v. 116, n. 5, p. 844-854, 2014.
Zanini, M.; Meyer, E.; Simon, S. Pulp inflammation diagnosis from clinical to inflammatory mediators: A systematic review. Journal of Endodontics, v. 43, n. 7, p. 1033-1051, 2017.
Zanoello, A. M.; Mazzanti, C. M.; Gindri, J. K.; Filappi, A.; Prestes, D.; Cecim, M. Efeito Protetor do Syzygiumcumini contra Diabetes mellitus induzido por aloxano em ratos. Acta Farmaceutica Bonaerense, v. 21, n. 1, p. 31-36, 2002.
